Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified key ...

A topical treatment, like a gel or lotion, to directly target skin cancer, which could be safer than oral treatments.

The governor of New York has basal cell carcinoma, a common type of skin cancer. Gov. Kathy Hochul (D) announced her ...

Drug rashes are a common side effect in people taking antiseizures, antibiotics, or anti-inflammatories. Find out specific ...

MURRAY, Utah (ABC4 Utah) – More than 800 Utahns will be diagnosed with skin cancer this year. Nationally, one in five people ...

Psoriasis itself doesn't make you immunocompromised, however, medications that treat the condition can suppress the immune ...

Skin cancer is the most common form of cancer nationwide each year, the Centers for Disease Control and Prevention (CDC) says ...

Melanoma -- the deadliest form of skin cancer -- isn't an equal opportunity cancer. A new study points up some important ...

taking certain steps now can help reduce your risk of developing skin cancer in the future. Change is the clearest indication of skin cancer, according to Faramarz Samie, M.D., a dermatologist at ...

Research on the supplement's health benefits is limited, but it is rich in compounds that have anti-inflammatory, antiviral, ...

No new safety concerns and consistent safety profiles were observed for long-term risankizumab use in patients with psoriasis and PsA.

Patients with RA receiving upadacitinib monotherapy vs methotrexate monotherapy achieved better clinical, radiographic, and patient-reported outcomes over 5 years.